Physician profile
Roy S Jones
NPI 1083640072
$3,670.35
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $149 · 2021: $1,059 · 2022: $1,261 · 2023: $1,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,185.79 | 2020-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $341.57 | 2019-2023 | Trulance, Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $228.82 | 2021-2023 | Entyvio |
| Janssen Biotech, INC. | $145.99 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $131.78 | 2020-2023 | Dificid |
| Janssen Scientific Affairs, LLC | $104.71 | 2019 | |
| Nestle Healthcare Nutrition INC. | $87.01 | 2021-2023 | |
| Celgene Corporation | $68.48 | 2022-2023 | Zeposia |
| Qol Medical, LLC | $68.17 | 2021-2022 | |
| Genzyme Corporation | $58.89 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $53.31 | 2022 | |
| Redhill Biopharma INC. | $34.35 | 2020-2021 | |
| Ardelyx, INC. | $31.22 | 2023 | Ibsrela |
| Ferring Pharmaceuticals INC. | $24.87 | 2022 | |
| Ironwood Pharmaceuticals, INC | $23.71 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $21.18 | 2019 | |
| Evoke Pharma, INC. | $16.70 | 2021 | |
| Lilly USA, LLC | $16.52 | 2023 | |
| Amgen INC. | $15.93 | 2022 | |
| Organon LLC | $11.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.